Evidence map›Paper›PMID 31519680›Full record

ArticleBMJ open2019

Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol for a cluster-randomised trial.

Katharine A Collins, Alphonse Ouedraogo, Wamdaogo Moussa Guelbeogo, Shehu S Awandu, Will Stone, Issiaka Soulama, Maurice S Ouattara, Apollinaire Nombre, Amidou Diarra, John Bradley and 5 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03705624 (P. Falciparum Infection Dynamics and Transmission to Inform Elimination), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03705624 nacompletednot on this map

P. Falciparum Infection Dynamics and Transmission to Inform Elimination (INDIE-1a)

TypeinterventionalSponsorLondon School of Hygiene and Tropical MedicineRan2018 to 2020Enrolled907ConditionsMalariaArmsEnhanced Community Case Management (CCM), Monthly Screening and Treatment (MSAT)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Katharine A CollinsDepartment or Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.ORCID 0000-0002-7080-2215
Alphonse OuedraogoDepartment of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Wamdaogo Moussa GuelbeogoDepartment of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Shehu S AwanduDepartment or Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
Will StoneDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
Issiaka SoulamaDepartment of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Maurice S OuattaraDepartment of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Apollinaire NombreDepartment of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Amidou DiarraDepartment of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
John BradleyMRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
Prashanth SelvarajInstitute for Disease Modeling, Bellevue, Washington, USA.
Jaline GerardinInstitute for Disease Modeling, Bellevue, Washington, USA.
Chris DrakeleyDepartment of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.
Teun BousemaDepartment or Medical Microbiology, Radboudumc, Nijmegen, The Netherlands teun.bousema@radboudumc.nl.
Alfred TionoDepartment of Biomedical Sciences, Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Centre National de Recherche et de Formation sur le Paludisme · BFLondon School of Hygiene & Tropical Medicine · GBRadboud University Nijmegen · NLBellevue Hospital Center · US

Funding

Medical Research Council MR/P02016X/1Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

introductionA large proportion of malaria-infected individuals in endemic areas do not experience symptoms that prompt treatment-seeking. These asymptomatically infected individuals may retain their infections for many months during which sexual-stage parasites (gametocytes) are produced that may be transmissible to mosquitoes. Reductions in malaria transmission could be achieved by detecting and treating these infections early. This study assesses the impact of enhanced community case management (CCM) and monthly screening and treatment (MSAT) on the prevalence and transmissibility of malaria infections. METHODS AND ANALYSIS: This cluster-randomised trial will take place in Sapone, an area of intense, highly seasonal malaria in Burkina Faso. In total, 180 compounds will be randomised to one of three interventions: arm 1 - current standard of care with passively monitored malaria infections; arm 2 - standard of care plus enhanced CCM, comprising active weekly screening for fever, and detection and treatment of infections in fever positive individuals using conventional rapid diagnostic tests (RDTs); or arm 3 - standard of care and enhanced CCM, plus MSAT using RDTs. The study will be conducted over approximately 18 months covering two high-transmission seasons and the intervening dry season. The recruitment strategy aims to ensure that overall transmission and force of infection is not affected so we are able to continuously evaluate the impact of interventions in the context of ongoing intense malaria transmission. The main objectives of the study are to determine the impact of enhanced CCM and MSAT on the prevalence and density of parasitaemia and gametocytaemia and the transmissibility of infections. This will be achieved by molecular detection of infections in all study participants during start and end season cross-sectional surveys and routine sampling of malaria-positive individuals to assess their infectiousness to mosquitoes. ETHICS AND DISSEMINATION: The study has been reviewed and approved by the London School of Hygiene and Tropical Medicine (LSHTM) (Review number: 14724) and The Centre National de Recherche et de Formation sur le Paludisme institutional review board (IRB) (Deliberation N° 2018/000002/MS/SG/CNRFP/CIB) and Burkina Faso national medical ethics committees (Deliberation N° 2018-01-010).Findings of the study will be shared with the community via local opinion leaders and community meetings. Results may also be shared through conferences, seminars, reports, theses and peer-reviewed publications; disease occurrence data and study outcomes will be shared with the Ministry of Health. Data will be published in an online digital repository. TRIAL REGISTRATION NUMBER: NCT03705624.

Indexed as

Asymptomatic InfectionsMalariaMass ScreeningAdultBurkina FasoCase ManagementChildCluster AnalysisDelivery of Health CareDisease Transmission, InfectiousFemaleHumansMalePlasmodium falciparumPrevalenceRandomized Controlled Trials as Topicasymptomatic infectionsdirect membrane feeding assaysgametocytemalariatransmission

Identifiers

PMID31519680
PMCPMC6747640
OpenAlexW2972897543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.